If nothing else, the US Health and Human Services Department’s decision to appeal the recent court decision striking down its direct-to-consumer advertising rule shows how badly the Trump Administration wants to keep swinging in its battle to lower drug prices.
Can’t Let Go: HHS Seeks To Overturn US Court Decision Striking Down DTC Ad Rule
The appeal is in keeping with the President Trump’s plan to stay active on drug pricing initiatives so he can claim victory on a key campaign promise.
